Effects of hormone therapy on ambulatory blood pressure in postmenopausal Korean women

Climacteric

Volumn 14, Issue 1, 2011, Pages 92-99

  Lee, D Y ^a   Kim, J Y ^a   Kim, J H ^b   Choi, D S ^a   Kim, D K ^a   Koh, K K ^c   Yoon, B K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

ambulatory blood pressure; hormone therapy; Menopause; micronized progesterone

Indexed keywords

CONJUGATED ESTROGEN; PROGESTERONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; ESTROGEN THERAPY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CIRCADIAN RHYTHM; COHORT STUDIES; DIASTOLE; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; MIDDLE AGED; PARITY; POSTMENOPAUSE; PREGNANCY; PROGESTERONE; PROGESTINS; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SYSTOLE;

EID: 79951649792     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.491924     Document Type: Article

References (41)

1. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72 (Pubitemid 28279924)
2. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53 (Pubitemid 38040534)
3. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77 (Pubitemid 46556472)
4. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-602 (Pubitemid 46961004)
5. Wiinber N, Hoegholm A, Christensen HR, et al. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995;8:978-86
6. Karpanou EA, Vyssoulis GP, Georgoudi DG, Toutouza MG, Toutouzas PK. Ambulatory blood pressure changes in the menstrual cycle of hypertensive women. Significance of plasma renin activity values. Am J Hypertens 1993;6:654-9 (Pubitemid 23268596)
7. Wilson M, Morganti AA, Zervoudakis I, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 1980;68:97-104 (Pubitemid 10207625)
8. Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension 2005;45:170-4 (Pubitemid 40179952)
9. Mueck AO, Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas 2004;49:235-40
10. Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit 2002;7:293-300 (Pubitemid 36140455)
11. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368-74
12. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539-46 (Pubitemid 29380290)
13. Verdecchia P. Reference values for ambulatory blood pressure and self-measured blood pressure based on prospective outcome data. Blood Press Monit 2001;6:323-7 (Pubitemid 34194888)
14. Howard BV, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: The Women's Health Initiative Observational Study. Circulation 2005;111:1462-70 (Pubitemid 40470639)
15. Mercuro G, Zoncu S, Piano D, et al. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998;11:909-13 (Pubitemid 28378402)
16. Zacharieva S, Atanassova I, Kirilov G, et al. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women. Climacteric 2002;5:293-9
17. Mills PJ, Farag NH, Matthews S, Nelesen RA, Berry CC, Dimsdale JE. Hormone replacement therapy does not affect 24-h ambulatory blood pressure in healthy non-smoking postmenopausal women. Blood Press Monit 2003;8:57-61 (Pubitemid 36677274)
18. Manwaring P, Morfis L, Diamond T, Howes LG. Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women. Blood Press 2000;9:22-7 (Pubitemid 30366122)
19. Seely EW, Brosnihan KB, Jeunemaitre X, et al. Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol 2004;60:315-21 (Pubitemid 38297121)
20. Sands RH, Studd JW, Crook D, Warren JB, Cruickshank J, Coats A. The effect of estrogen on blood pressure in hypertensive postmenopausal women. Menopause 1997;4:115-9 (Pubitemid 127729505)
21. White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension. Hypertension 2006;48:246-53 (Pubitemid 44309819)
22. Stefano GB, Prevot V, Beauvillain JC, et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 2000;101:1594-7 (Pubitemid 30180897)
23. Arnal JF, Scarabin PY, Tremollieres F, Laurell H, Gourdy P. Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol 2007;18:554-60 (Pubitemid 47462209)
24. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001;103:2903-8 (Pubitemid 32578126)
25. Da Costa LS, De Oliveira MA, Rubim VS, et al. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women. Am J Cardiol 2004;94:1453-6 (Pubitemid 39556225)
26. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the reninangiotensin system in postmenopausal women. Circulation 1997;95:39-45 (Pubitemid 27029940)
27. Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982;144:511-18 (Pubitemid 12002825)
28. Wren BG, Routledge AD. The effect of type and dose of oestrogen on the blood pressure of post-menopausal women. Maturitas 1983;5:135-42 (Pubitemid 13040775)
29. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208
30. Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999;33:1190-4 (Pubitemid 29230972)
31. Rylance PB, Brincat M, Lafferty K, et al. Natural progesterone and antihypertensive action. Br Med J 1985;290:13-14 (Pubitemid 15075974)
32. Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005;45:240-5 (Pubitemid 40179967)
33. De Lignieres B. Oral micronized progesterone. Clin Ther 1999;21:41-60 (Pubitemid 29106689)
34. Barbagallo M, Dominguez LJ, Licata G, et al. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension 2001;37:142-7 (Pubitemid 32064252)
35. Chataigneau T, Zerr M, Chataigneau M, et al. Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause 2004;11:255-63 (Pubitemid 40362179)
36. Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetatein human endothelial cells. Endocrinology 2004;145:5745-56 (Pubitemid 39564616)
37. Szmuilowicz ED, Adler GK, Ricchiuti V, Hopkins PN, Seely EW. Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women. J Clin Endocrinol Metab 2007;92:4738-41 (Pubitemid 350223453)
38. Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 2005;18:797-804 (Pubitemid 40745265)
39. Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs 2007;67(Suppl 2):3-13 (Pubitemid 350114591)
40. Wong ND, Pio JR, Franklin SS, L'Italien GJ, Kamath TV, Williams GR. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 2003;91:1421-6 (Pubitemid 36694717)
41. Mancia G, Omboni S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;8:311-15